(11-Ethyl-9,14-dihydrodibenzo[f,h]pyrrolo[1,2-b]isoquinoline-12,13-diyl)dimethanol

ID: ALA4777835

Chembl Id: CHEMBL4777835

PubChem CID: 162644095

Max Phase: Preclinical

Molecular Formula: C24H23NO2

Molecular Weight: 357.45

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CCc1c(CO)c(CO)c2n1Cc1c(c3ccccc3c3ccccc13)C2

Standard InChI:  InChI=1S/C24H23NO2/c1-2-23-21(13-26)22(14-27)24-11-19-17-9-5-3-7-15(17)16-8-4-6-10-18(16)20(19)12-25(23)24/h3-10,26-27H,2,11-14H2,1H3

Standard InChI Key:  DSRXGXOWNYMGGC-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4777835

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 357.45

Molecular Weight (Monoisotopic): 357.1729

AlogP: 4.29

#Rotatable Bonds: 3

Polar Surface Area: 45.39

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 4.05

CX LogD: 4.05

Aromatic Rings: 4

Heavy Atoms: 27

QED Weighted: 0.47

Np Likeness Score: 0.18

References

1. Patel AS,Jain V,Rao VN,Lin YW,Shah A,Lai KC,Su TL,Lee TC.  (2020)  Design, synthesis and antitumour evaluation of pyrrolo[1,2-f]-phenanthridine and dibenzo[f,h]pyrrolo[1,2-b]isoquinoline derivatives.,  202  [PMID:32622270] [10.1016/j.ejmech.2020.112516]

Source

Source(1):

• Scientific Literature